Prostatis Group Portfolio holdings
Top Buys
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
+$772M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$490M |
| 3 |
Home Depot
HD
|
+$415M |
| 4 |
Amplify CWP Enhanced Dividend Income ETF
DIVO
|
+$368M |
| 5 |
Invesco S&P 500 Equal Weight Technology ETF
RSPT
|
+$353M |
Sector Composition
| 1 | Technology | 3.21% |
| 2 | Industrials | 2.5% |
| 3 | Energy | 1.77% |
| 4 | Financials | 1.66% |
| 5 | Consumer Staples | 1.63% |
Similar funds
Prostatis Group's Q3 2023 Portfolio in Review
As of Q3 2023, Prostatis Group held 261 positions worth $205M, down 4.8% from $215M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Prostatis Group withdrew a net $6.54B in Q3 2023, closing 149 positions and reducing 87 holdings. Its most notable exit was ARK Autonomous Technology & Robotics ETF, an estimated $10.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.2% of assets, up from 3% a quarter earlier, followed by Industrials and Energy.
Against the trend, Prostatis Group opened a new position in State Street SPDR Bloomberg 1-3 Month T-Bill ETF worth $22.9M.
- Prostatis Group's largest Q3 2023 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 249,300 shares worth $22.9M.
- Prostatis Group added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q3 2023, an estimated $4.64M increase.
- Prostatis Group's biggest Q3 2023 reduction was Thermo Fisher Scientific, cutting an estimated $772M.
- Prostatis Group fully exited ARK Autonomous Technology & Robotics ETF in Q3 2023, selling an estimated $10.3M.
- Prostatis Group's ten largest holdings make up 53% of its $205M portfolio in Q3 2023.
- Prostatis Group opened 11 new positions and closed 149 in Q3 2023.
- Prostatis Group's portfolio value fell 4.8% quarter-over-quarter to $205M.
Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.